Male Infertility . Virtual Preceptorship:
The Male partner in front stage to improve ART succes
3 May - 30 june 2021


Andrology, the branch of medicine concerned with male sexual and reproductive health, emerged as a specialty at the end of the nineteenth century. However, it was not until the latter half of the past century that andrology had been recognized as one of the most intriguing sub-specialties of human reproduction. The demand for andrologists and reproductive urologists is increasing; however, there are insufficient experts to keep pace with the requirement.

The scope of modern andrology covers a broad spectrum from genetic studies to assisted reproduction techniques, and there is a clear need for updating healthcare professionals in these aspects.

This preceptorship will offer urologists, gynecologists, embryologists, andrologists and scientists working in ART an opportunity to learn the tools to implement reproductive andrology in a Fertility Center. The participants will be guided by international experts through lectures, debates and interactive discussions.
Apart from providing new insights into male infertility, this educational activity will give a guided journey through a modern centre specialise

Learning Objectives

Target Audience

The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.

Male Infertility Virtual Preceptorship:

The Male partner in front stage to improve ART succes

3 may · 30 june 2021

Preliminary Programme

Download the PDF preliminary programme


The official language of the activity will be English. Translation in Chinese; Portuguese; Spanish for the video lectures will be provided.

Visual Maps

PDFs to download

Office Based Minimally Invasive MESA

Microdissection Testicular Sperm Extraction


Sandro Esteves

Campinas, Brazil

R. Matthew Coward

Chapel Hill, NC, USA


Carlo Alviggi

Naples, Italy

Robert Fisher

Hamburg, Germany

Peter Humaidan

Aarhus, Denmark


Androfert · Andrology and Human Reproduction Clinic Campinas, Brazil

Sandro C. Esteves

Medical Director Professor of Urology, University of Campinas (UNICAMP)

Rita Figueira

Laboratory Supervisor

Arnold P. Achermann

Fellow in Male Infertility

Ricardo Miyaoka

Reproductive Urologist Professor of Urology, University of Campinas (UNICAMP)

Fabiola Bento

Quality Manager

Fabiana Y. Nakano

Consultant, Reproductive Endocrinology and Infertility

Fertility Center Hamburg (FCH) Hamburg, Germany

Robert Fischer

Reproductive Endocrinologist

Kimberly Kienast

Head of the IVF and Andrology Laboratoriesy

Wolfgang Schulze


University of North Carolina (UNC) Fertility Male Reproductive Medicine and Surgery Chapel Hill, NC, USA

R. Matthew Coward

Director of Male Reproductive Medicine and Surgery

Vaishnavi Purusothaman

Fellow in Reproductive Endocrinology and Infertility

Steven L. Young

Professor of Obstetrics and Gynecology

Caitlin Boylan


John A. Lee

Fellow in Andrology

Daquan Dock

Andrology Supervisor

Audrey S. Garneau

Fellow in Reproductive Endocrinology and Infertility

Instituto Valenciano de Infertilidad (IVI) Valencia, Spain

Nicolás Garrido

Director of the Andrology Laboratory and Sperm Bank

Educational Format

The virtual preceptorship will feature:

7 Video lectures

that will be released throughout the course period with subtitles in Chinese, Portuguese, Spanish.

6 Scribing Mapping

Of the video lectures that were released throughout the last Virtual World Conference on Luteinizing Hormone in ART: A New Galaxy is Born!

3 live sessions

(practical session in three ‘host’ clinics) will be streamed live and each session will provide the opportunity for more practical in-depth learning.

Chat room

During the three live sessions, users will be able to enter the chat room to discuss and ask interesting topics and debate with colleagues.

Diploma and Certificate

After competition of the activities HCP will receive Certificate and Diploma signed by the Chairs.


with a collection of articles related to the program will be provided.

Case study submission

3 live practical sessions in three ‘host’ clinics, has engaged a group of participants that have prepared case studies and became an “Active participant” in the live sessions.

Live Session Videos

Play Video
Play Video
Play Video

Video Lectures

Play Video
Play Video
Play Video
Play Video
Play Video
Play Video
Play Video

Library Videos

Play Video
Play Video

Library Slides

Preliminary Programme



This program is designed in partnership with the Brazilian Society of Urology (São Paulo Section) and the Portuguese Society of Reproductive Medicine.

CME Provider

Med.E.A – Medical Education Academy

Host Clinics


Med.E.A Srl educational programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.
These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. Our educational activities are supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, Germany; FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S., Androfert Andrology & Human Reproduction Clinic; MVZ Fertility Center Hamburg GmbH; University of North Carolina at Chapel Hill; Reproductive Medicine Agency (Nova Clinic)

· Sandro C. Esteves ·

Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a Fertility Center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the State University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.

He obtained his MD. degree in 1990 from the Faculty of Medical Sciences of UNICAMP, Brazil. Subsequently, he completed his Urology residency at the same institution and a postdoctoral fellowship program at the Glickman’s Urological Institute at the Cleveland Clinic Foundation in the United States. He earned a master’s in Surgery from UNICAMP and a Ph.D. in Urology from the Federal University of S o Paulo (EPM-UNIFESP). Dr. Esteves has contributed to our understanding of male infertility with over 25 years of experience in clinical and academic settings. He has emphasized the limitations of basic semen analysis, the importance of assessing sperm DNA fragmentation in male infertility evaluations, and highlighted the relevance of varicocele and its treatment in enhancing male fertility prospects. He has also published extensively on his clinical experience with microsurgical treatment of infertile men, as well as on hormonal therapy for improving sperm retrieval success of men with non-obstructive azoospermia. Dr. Esteves has helped design novel stratification systems for infertile men with testicular dysfunction, for whom fertility prospects may improve after hormonal therapy, and for low prognosis infertile women undergoing ART. Dr. Esteves is a prolific author, and his research comprises over 350 published papers, numerous book chapters, and textbooks. With a Hirsch index of 71 and a citation count of around 17K, he is ranked among the top 1% of global researchers by the Science-Wide Author Databases of Standard Citation Indicators (Elsevier). Prof. Esteves plays an active role in the scientific community as a member of the Faculty Opinions in reproductive endocrinology and infertility and as a founding member of the POSEIDON group for reproductive medicine. Additionally, he holds positions as Associate Editor/Section Editor in several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He also serves on the editorial boards of many scientific journals, including Nature Reviews Urology. Dr. Esteves’ clinic has been at the forefront of implementing cleanroom technology in the ART laboratory and adhering to ISO 9001 quality standards in Brazil. The ANDROFERT team is renowned for its strict quality standards and remarkable success rates in treating couples with male factor infertility. As a seasoned speaker, Dr. Esteves delivers over 50 lectures annually in Brazil and internationally. He has received multiple research grants and awards from national and international societies and currently holds the position of head of the Department of Andrology at the Brazilian Society of Human Reproduction.

· Carlo Alviggi ·

Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endicrinology and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively and has been invited to lecture at over 200 international meetings dealing with reproductive medicine and gynaecological endocrinology; he is also starter and co-founder of the Poseidon group, an international collaborative network dedicated to low prognosis patients in Assisted Reproductive Technology and vice-President of the “Società Italiana di Fertilità e Sterilità – Medicina della Riproduzione”.

· Robert Fischer ·

Robert Fischer is the founder and Medical Director of the Fertility Center Hamburg (FCH) in Hamburg, Germany. Dr Fischer trained in obstetrics and gynaecology at the University Hospital of Münster, Germany, from 1979 to 1982 and at the Queen’s Medical Centre, University of Nottingham, UK. In 1983, Dr Fischer pioneered the first German outpatient IVF unit in Hamburg and became its Medical Director. The unit moved to a new location in 1998, and its name was changed to the “Fertility Center Hamburg”.

In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025). Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres. He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group);  Member of the  Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of  Med.E.A.( Medical Education Academy)

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. He is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. Finally, he is also co-founder of the APHRODITE group which suggested a new classification of the infertile male into five sub-groups who might benefit from medical treatment in terms of spermatogenesis. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 270 + articles (H-index 70, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.